Evidence map›Paper›PMID 35444815›Full record

ArticleCurrent health sciences journal

Long Term Respiratory Follow-Up for COVID-19 Patients a Multicenter Study.

Daliborka Bursac, Dimitris Petridis, Bojan Zaric, Tomi Kovacevic, Vladimir Stojsic, Tatjana Sarcev, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, Christoforos Kosmidis and 10 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Daliborka BursacFaculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia.
Dimitris PetridisDepartment of Food Science and Technology, International Hellenic University, School of Geotechnical Sciences, Aristotle University of Thessaloniki, Greece.
Bojan ZaricFaculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia.
Tomi KovacevicFaculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia.
Vladimir StojsicFaculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia.
Tatjana SarcevFaculty of Medicine, University of Novi Sad, Institute for Pulmonary Diseases of Vojvodina, Novi Sad, Serbia.
Haidong HuangDepartment of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Chong BaiDepartment of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Wolfgang Hohenforst-SchmidtDepartment of Cardiology/Pulmonology/Intensive Care/Nephrology, Sana Clinic Group Franken, "Hof" Clinics, University of Erlangen, Hof, Germany.
Christoforos Kosmidis3rd Surgery Department-COVID-19 Infectious Disease, "AHEPA" University Hospital, Medical school of Health Sciences, Aristotle University of Thessaloniki, Greece.
Konstantinos Sapalidis3rd Surgery Department-COVID-19 Infectious Disease, "AHEPA" University Hospital, Medical school of Health Sciences, Aristotle University of Thessaloniki, Greece.
Konstantinos Romanidis2nd Department of Surgery, General University Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Nikolaos CourcoutsakisRadiology Department, General University Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Aimilios Lallas1st Department of Dermatology, Medical school of Health Sciences Aristotle University of Thessaloniki, Greece.
Giorgos TsakaldimisUrology Department, "Saint Dimitrios" General Hospital, Thessaloniki, Greece.
Kyriakoula ChatzimichaelNeonatology Department, "Hippokration" General Hospital, Thessaloniki, Greece.
Chrysanthi SardeliDepartment of Pharmacology&Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.
Dimitris MatthaiosOncology Department, General Hospital of Rhodos, Greece.
Paul Zarogoulidis3rd Surgery Department-COVID-19 Infectious Disease, "AHEPA" University Hospital, Medical school of Health Sciences, Aristotle University of Thessaloniki, Greece.
Chrysanthi KarapantzouEar, Nose and Throat (ENT) Department, Ludwig-Maximilians University of Munich, Germany.
University of Novi Sad · RSInstitute for Pulmonary Diseases of Vojvodina · RSSecond Military Medical University · CNPolyclinic General Hospital · GRSana Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe first wave of the COVID-19 pandemic initiated officially in October 2020. Since then several observations have been made regarding the disease and its symptoms. PATIENTS AND

methodsWe included eighty seven in our observational study. Our main aim was to investigate their long term respiratory follow-up in correlation with their initial radiological and laboratory findings and values. The nose swab PCR test for COVID-19 was used for diagnosis. Patients were monitored at 3 and 6 months after their hospital reception whereas basic parameters of health condition (smoking, PO2, SPO2, WBC, CXR, CRP, intercurrent findings, days of nursing, colchicine administration) in joint with gender and age were recorded.

resultsMales seem more susceptible to the viral disease than females in a ratio 1,8:1. The parameters FEV1 and FVC (as % relative changes) were not affected, apart from the DLCO to which CRP (in loge+1 transformation) and SPO2 showed a statistically significant effect.

conclusionNone of these patients were intubated, or admitted to the intensive care unit. The respiratory function is affected by the virus and the effect is reversed within the first three months. Males are more affected and the radiological and laboratory findings are associated with the respiratory functions.

Indexed as

COVID-19DLCOFEV1FVCrespiratory functionsrespiratory infection

Identifiers

PMID35444815
PMCPMC8987475
OpenAlexW4224309074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.